Literature DB >> 11159713

Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints.

S D Gauldie1, D S McQueen, R Pertwee, I P Chessell.   

Abstract

The effects of the endogenous cannabinoid anandamide were studied on peripheral, polymodal nociceptors recorded from normal and chronically inflamed (Freund's adjuvant) knee joint afferents in rats anaesthetized with pentobarbitone. Anandamide (860 nmol) caused a rapid, short lasting excitation of a sub-population of capsaicin-sensitive nociceptive afferents in normal knee joints (7.2+/-2.3 impulses s(-1); n=15 units from five animals). In arthritic joints there were 9.7+/-3.0 impulses s(-1) (n=11 from six animals), which was not significantly different from normal joints. The excitation was dose dependent (8.6 - 2900 nmol) and mediated by activation of the vanilloid receptor (VR(1)) as it was abolished by the VR1 antagonist capsazepine (1 mg kg(-1)). Our results show that anandamide, at high doses, can activate nociceptive afferents innervating the rat knee joints, in contrast with its widely described analgesic actions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159713      PMCID: PMC1572613          DOI: 10.1038/sj.bjp.0703890

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  Anandamide: an endogenous activator of the vanilloid receptor.

Authors:  D Smart; J C Jerman
Journal:  Trends Pharmacol Sci       Date:  2000-04       Impact factor: 14.819

2.  Anandamide and the question of its functional role for activation of capsaicin receptors.

Authors:  J Szolcsányi
Journal:  Trends Pharmacol Sci       Date:  2000-06       Impact factor: 14.819

3.  Are cannabinoids endogenous ligands for the VR1 capsaicin receptor?

Authors:  J Szolcsányi
Journal:  Trends Pharmacol Sci       Date:  2000-02       Impact factor: 14.819

4.  Anandamide - the other side of the coin.

Authors:  P M Zygmunt; I Julius; I Di Marzo; E D Högestätt
Journal:  Trends Pharmacol Sci       Date:  2000-02       Impact factor: 14.819

5.  Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens.

Authors:  R A Ross; T M Gibson; H C Brockie; M Leslie; G Pashmi; S J Craib; V Di Marzo; R G Pertwee
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

Review 6.  Cannabinoids as potential new analgesics.

Authors:  J A Fuentes; M Ruiz-Gayo; J Manzanares; G Vela; I Reche; J Corchero
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

7.  The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1).

Authors:  D Smart; M J Gunthorpe; J C Jerman; S Nasir; J Gray; A I Muir; J K Chambers; A D Randall; J B Davis
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

8.  Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors.

Authors:  Jennelle Durnett Richardson; Sonja Kilo; Kenneth M Hargreaves
Journal:  Pain       Date:  1998-03       Impact factor: 6.961

9.  Differential expression of the mRNA for the vanilloid receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its downregulation by axotomy.

Authors:  G J Michael; J V Priestley
Journal:  J Neurosci       Date:  1999-03-01       Impact factor: 6.167

10.  P2X receptor-mediated excitation of nociceptive afferents in the normal and arthritic rat knee joint.

Authors:  E Dowd; D S McQueen; I P Chessell; P P Humphrey
Journal:  Br J Pharmacol       Date:  1998-09       Impact factor: 8.739

View more
  16 in total

1.  Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen.

Authors:  S Holt; J Nilsson; R Omeir; G Tiger; C J Fowler
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

2.  Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.

Authors:  K O Jonsson; S Vandevoorde; D M Lambert; G Tiger; C J Fowler
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

Review 3.  Mechanisms and Mediators That Drive Arthritis Pain.

Authors:  Eugene Krustev; Danielle Rioux; Jason J McDougall
Journal:  Curr Osteoporos Rep       Date:  2015-08       Impact factor: 5.096

4.  Inhibitory effect of amiloride and gadolinium on fine afferent nerves in the rat knee: evidence of mechanogated ion channels in joints.

Authors:  Bernd Heppelmann; Jason J McDougall
Journal:  Exp Brain Res       Date:  2005-10-29       Impact factor: 1.972

5.  'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism.

Authors:  Darren Smart; Kent-Olov Jonsson; Séverine Vandevoorde; Didier M Lambert; Christopher J Fowler
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

Review 6.  Endocannabinoid mechanisms of pain modulation.

Authors:  Andrea G Hohmann; Richard L Suplita
Journal:  AAPS J       Date:  2006-11-17       Impact factor: 4.009

7.  Excitation of cutaneous C nociceptors by intraplantar administration of anandamide.

Authors:  Carl Potenzieri; Thaddeus S Brink; Donald A Simone
Journal:  Brain Res       Date:  2009-03-10       Impact factor: 3.252

8.  The cannabinomimetic arachidonyl-2-chloroethylamide (ACEA) acts on capsaicin-sensitive TRPV1 receptors but not cannabinoid receptors in rat joints.

Authors:  Chris L Baker; Jason J McDougall
Journal:  Br J Pharmacol       Date:  2004-07-26       Impact factor: 8.739

9.  Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve.

Authors:  Manabu Kagaya; Jasmine Lamb; Jon Robbins; Clive P Page; Domenico Spina
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

Review 10.  Arthritis and pain. Neurogenic origin of joint pain.

Authors:  Jason J McDougall
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.